Publications by authors named "D B Ingham"

Purpose: We tested whether blinatumomab (Blina) is effective as a toxicity-sparing alternative to first-line intensive chemotherapy in children and young persons (CYP) with B-ALL who were chemotherapy-intolerant or chemotherapy-resistant.

Methods: Data were collected for consecutive CYP (age 1-24 years) with Philadelphia chromosome-positive or Philadelphia chromosome-negative B-ALL who received Blina as first-line therapy. Blina was given as replacement for postremission intensive chemotherapy to patients with chemotherapy intolerance or resistance.

View Article and Find Full Text PDF

The management of soybean rust (SBR) caused by the obligate fungus mostly relies on the use of synthetic fungicides, especially in areas where the disease inflicts serious yield losses. The reliance on synthetic fungicides to manage this disease has resulted in resistance of populations to most fungicides. In this study, bacteria isolated from diverse environments were evaluated for their biocontrol potential against using soybean detached-leaf method and on-plant in the growth chamber, greenhouse, and field.

View Article and Find Full Text PDF
Article Synopsis
  • Some kids who had a type of blood cancer called acute lymphoblastic leukemia (ALL) might get another type of cancer called non-Hodgkin lymphoma (NHL) after their treatment.
  • In a study of 85 kids with NHL after ALL, most cases happened during or soon after their main treatment.
  • Many of these kids had weakened immune systems, which is important to know for better and faster diagnosis and treatment.
View Article and Find Full Text PDF

We report the case of a school-aged boy who presented with clinical features suggesting acute appendicitis. However, further imaging which included CT, demonstrated an inflammatory mass involving the transverse colon raising the suspicion of lymphoma. He then developed intestinal obstruction, and in view of the rapid progression of the disease, he was thought to have non-Hodgkin's lymphoma.

View Article and Find Full Text PDF

Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRDs) affect 6 million Americans, and they are projected to have an estimated health care cost of $355 billion for 2021. A histopathological hallmark of AD and many ADRDs is the aberrant intracellular accumulation of the microtubule-associated protein tau. These neurodegenerative disorders that contain tau aggregates are collectively known as tauopathies, and recent structural studies have shown that different tauopathies are characterized by different "strains" of tau filaments.

View Article and Find Full Text PDF